Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone.
Journal
Minerva endocrinologica
ISSN: 1827-1634
Titre abrégé: Minerva Endocrinol
Pays: Italy
ID NLM: 8406505
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
entrez:
22
1
2021
pubmed:
23
1
2021
medline:
5
11
2021
Statut:
ppublish
Résumé
The differential diagnosis of anovulatory disorders is actually based on serum gonadotrophin and estradiol levels. However, several other markers have been proposed. The purpose of this review was to underline the role of anti-Müllerian hormone (AMH) as a possible marker in differential diagnosis of the anovulatory diseases and its use as a predictive marker of prognosis. In this article we discuss clinical and experimental evidences actually existing in literature and we suggest new potential clinical application of AMH.
Identifiants
pubmed: 33478206
pii: S0391-1977.20.03390-8
doi: 10.23736/S0391-1977.20.03390-8
doi:
Substances chimiques
Anti-Mullerian Hormone
80497-65-0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM